Ethereum whales bet $417mln on a rebound – Will ETH charts agree?

ambcryptoPublished on 2025-10-16Last updated on 2025-10-16

Key Takeaways 

Why is Ethereum attracting whale interest?

Whales accumulated over $417 million worth of ETH despite the market downturn, signaling strong long-term confidence.

How do reserves and sentiment shape Ethereum’s outlook?

Falling Exchange Reserves and improving Weighted Sentiment signal rising accumulation pressure.


Since mid-October, Ethereum [ETH] has shown renewed investor interest after whales accumulated 104,336 ETH worth $417 million from Kraken and BitGo wallets. 

This massive inflow, led by Bitmine, coincided with Tom Lee’s forecast that Ethereum could reach $10,000 by year-end. 

On top of that, the timing of this accumulation signaled that high-net-worth investors remained confident in Ethereum’s long-term potential. 

Consequently, the whale-driven optimism could serve as a key catalyst for a major recovery if technical conditions align favorably.

Can Ethereum break out of its descending channel soon?

Ethereum’s daily chart revealed a well-defined descending channel, with price rebounding from the lower trendline near $3,676 at press time.

The recent upswing toward $4,060 suggested that bullish momentum is gradually returning. 

A sustained move above $4,269 could trigger a breakout toward $4,950, marking the end of the multi-week correction phase. 

However, if rejection occurs at the midline resistance, Ethereum may briefly retest the $3,800 demand zone before resuming upward movement. 

Ethereum price actionEthereum price action

Source: TradingView

Shrinking reserves = mounting accumulation pressure

Ethereum’s Exchange Reserves dropped 4.26% to $62.44 billion at press time. It meant that more tokens were leaving exchanges for cold storage. 

Such movement often reflects growing investor confidence, as traders remove holdings from sell-ready environments. 

This supply contraction could amplify price sensitivity to buying pressure, especially when paired with large-scale whale purchases. 

Additionally, the recent accumulation suggested that institutional investors were positioning for a medium-term rebound rather than short-term speculation. 

Source: CryptoQuant

Case of improving sentiment among investors

Santiment data showed Ethereum’s Social Dominance climbed to 7.11%, while Weighted Sentiment improved to -0.483 from deeper lows, at the time of writing. The combination indicated a slow but meaningful recovery in market confidence. 

Community engagement had intensified following Bitmine’s massive ETH acquisition, suggesting renewed attention from retail traders. 

However, sentiment remained mixed as macro uncertainty persists, making sustained optimism crucial for further price advancement. 

As discussions about Ethereum’s fundamentals grow, network confidence could strengthen enough to support a sustained breakout above $4,200 in the near term.

Source: Santiment

Can whale conviction reignite Ethereum’s next rally?

Ethereum’s rising whale accumulation, declining Exchange Reserves, and improving sentiment collectively strengthen the bullish outlook. 

If Ethereum breaks above the $4,269 resistance, it could confirm renewed momentum toward $4,950 in the coming weeks. Overall, Ethereum’s current setup signals that a decisive breakout could mark the beginning of its next major rally phase.

Share

Trending Cryptos

Related Reads

Haiwei Huaxin's Official Seal Seized by Over a Hundred People, High-Stakes Corporate Battle's 'Nuclear Deterrence' in Action Again

On August 18th, Haowei Huaxin, a semiconductor firm specializing in gallium arsenide and gallium nitride wafers, reported that over a hundred individuals forcibly entered its offices and seized the company's official seals from a safe, including the corporate, contract, and party committee seals. The incident is the latest escalation in a protracted control dispute. Haowei Huaxin, established in 2010, was originally a joint venture. Control became contested after 2021 when Zhenwei Financial Holding injected capital, becoming the largest shareholder (34.01%), while former parent Haite High-Tech's stake was diluted to 33.79%. An agreed-upon governance structure collapsed, leading to mutual accusations. Haite claimed it was locked out of the subsidiary's premises, while also alleging improper management like livestock being kept on the chip fabrication site. After state-owned Qingdao Haiyue Holdings took over Zhenwei's stake in 2023, Haite accused it of illegally seizing control. Despite Haite winning several legal battles in 2024-2026, which affirmed its rights to nominate directors and the chairman, it failed to regain physical control or recover the seals. The stakes are high: market valuations for Haite's stake in Haowei Huaxin are estimated between 3.7 to 5 billion USD, yet it is only valued at about 83 million USD on Haite's books. Losing control effectively jeopardizes a significant portion of Haite's value. In response to the seal seizure, Haite framed it as a "shareholder rights protection" action agreed upon by five shareholders. This mirrors a pattern in Chinese corporate disputes where seizing physical seals becomes a tactic to paralyze the opponent's daily operations, seen in past conflicts at companies like Dangdang and Bitmain. However, such actions don't resolve underlying ownership issues; the opposing party can report the seals stolen, declare them void, and apply for new ones, albeit with significant delay. The incident underscores how fragile corporate governance can devolve into physical confrontations over symbols of authority, with control ultimately determined by law and shareholding, not possession of a seal.

marsbit29m ago

Haiwei Huaxin's Official Seal Seized by Over a Hundred People, High-Stakes Corporate Battle's 'Nuclear Deterrence' in Action Again

marsbit29m ago

Bernstein Interprets MRNA's 177% Surge: What's Fundamentals and What's Hype?

Bernstein's analysis of Moderna's 177% stock surge following positive Phase 3 results for its individualized neoantigen therapy (INT) in melanoma distinguishes fundamental drivers from market speculation. The clinical breakthrough is real: the INTerpath-001 trial met its primary and key secondary endpoints, providing crucial validation for mRNA technology in oncology beyond infectious diseases. However, Bernstein argues the magnitude of the stock move cannot be justified by this single trial's fundamentals alone. The surge was amplified by three key factors: 1) A re-rating of Moderna's mRNA platform potential for expansion into other cancers, 2) A massive short squeeze, given ~15% of shares were sold short pre-announcement, and 3) The compelling "cancer vaccine" narrative that fueled broader investor enthusiasm. While the melanoma success is significant, Bernstein cautions that replication in lung, kidney, and bladder cancers—which have different immunogenicity—is not guaranteed. Furthermore, INT's commercial model faces challenges: it's a personalized treatment, not a mass-market vaccine, implying higher production costs and potential margin pressures despite a projected multi-billion dollar peak sales opportunity. The report also notes sector rotation, with some funds moving from crowded AI/semiconductor trades into defensive healthcare stocks, adding further momentum. In conclusion, Bernstein maintains a "Market-Perform" rating and a $45 price target, far below the post-surge price. It views the current valuation as pricing in an optimistic multi-cancer platform success and efficient commercialization that are yet to be proven. The clinical inflection point is clear, but the earnings inflection point awaits validation across future trials and commercial execution.

marsbit29m ago

Bernstein Interprets MRNA's 177% Surge: What's Fundamentals and What's Hype?

marsbit29m ago

Trading

Spot

Hot Articles

Discussions

Welcome to the HTX Community. Here, you can stay informed about the latest platform developments and gain access to professional market insights. Users' opinions on the price of ETH (ETH) are presented below.

活动图片